Skip to main content
64°
Mostly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novamind Inc
(OP:
NVMDF
)
N/A
UNCHANGED
Last Price
Updated: 3:36 PM EDT, Jun 13, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novamind Inc
< Previous
1
2
3
Next >
Novamind Opens 6th Integrative Psychiatry Clinic, Adds 3rd Clinical Research Site
September 30, 2021
TORONTO, ON / ACCESSWIRE / September 30, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is...
From
Novamind Inc.
Via
AccessWire
Novamind Announces DTC Eligibility for its Common Shares
September 24, 2021
TORONTO, ON / ACCESSWIRE / September 24, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is...
From
Novamind Inc.
Via
AccessWire
Novamind to Present at Benzinga Healthcare Conference
September 23, 2021
Novamind to be featured in panel discussion on the disruptive potential of psychedelic medicine in mental healthcare TORONTO, ON / ACCESSWIRE / September 23, 2021 / Novamind Inc....
From
Novamind Inc.
Via
AccessWire
Novamind Announces Inclusion in NYSE Listed AdvisorShares Psychedelics ETF
September 20, 2021
TORONTO, ON / ACCESSWIRE / September 20, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is...
From
Novamind Inc.
Via
AccessWire
Novamind to Present at Life Sciences Investor Forum
September 14, 2021
TORONTO, ON / ACCESSWIRE / September 14, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is...
From
Novamind Inc.
Via
AccessWire
Novamind to Serve as Research Site for Karuna Therapeutics Late-Stage Clinical Trial
September 13, 2021
Cedar Clinical Research to Host Phase III Trial for Investigational Therapy for Schizophrenia TORONTO, ON / ACCESSWIRE / September 13, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or...
From
Novamind Inc.
Via
AccessWire
Psychedelic Medicine's Top CEOs: Who's Running The Biggest Companies In This Booming Industry?
September 09, 2021
By Natan Ponieman and Javier Hasse The psychedelic medicine industry is growing by leaps and bounds. Leading this charge is a group of ambitious and visionary corporate...
Via
Benzinga
Novamind Uplists to OTCQB Venture Market
September 09, 2021
TORONTO, ON / ACCESSWIRE / September 9, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is...
From
Novamind Ventures Inc.
Via
AccessWire
Novamind to Present at H.C. Wainwright 23rd Annual Global Investment Conference
September 08, 2021
TORONTO, ON / ACCESSWIRE / September 8, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is...
From
Novamind Inc.
Via
AccessWire
Psychedelic Drug Industry Report Card For 2021
September 01, 2021
In assessing the psychedelic drug industry, a primary focus for investors is drug development.
Via
Talk Markets
Novamind Divests Non-Core Retreat Investment
August 11, 2021
TORONTO, ON / ACCESSWIRE / August 11, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today...
From
Novamind Inc.
Via
AccessWire
Which Psychedelic Drug Has The Most Commercial Potential?
August 10, 2021
As the Mental Health Crisis has become a mental health pandemic, clinical research on psychedelic drugs is showing that these substances are the best – and only – option to address this crisis.
Via
Talk Markets
Novamind Strengthens Mental Health Expertise, Adds Communications Leader
August 06, 2021
Samantha DeLenardo joins from CAMH, Canada's largest mental health teaching hospital and leader in mental health research TORONTO, ON / ACCESSWIRE / August 6, 2021 / Novamind Inc., (CSE:NM)(OTC...
From
Novamind Inc.
Via
AccessWire
Exposures
COVID-19
Psyched: Field Trip Uplists To Nasdaq, MindMed To Study DMT, Atai Launches New Subsidiary, AOC's Psychedelics Amendment Rejected
August 02, 2021
Last week in Psychedelics:
Via
Benzinga
Novamind Opens 5th Clinic Location Specialized in Integrative Psychiatry for Patients with Treatment-Resistant Conditions
July 29, 2021
Company executes organic growth mandate, on track to open four new clinics by Q3 2021 TORONTO, ON / ACCESSWIRE / July 29, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind" or the...
From
Novamind Inc.
Via
AccessWire
Novamind Has Applied to Have its Common Shares Posted for Trading on the OTCQB in the United States
July 21, 2021
Aims to increase visibility and facilitate investment for United States investors TORONTO, ON / ACCESSWIRE / July 21, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind" or the...
From
Novamind Inc.
Via
AccessWire
Novamind Selected as Research Site for Bionomics' PTSD Clinical Trial
July 08, 2021
Cedar Clinical Research to Host Phase IIb Trial for a Novel PTSD Treatment TORONTO, ON / ACCESSWIRE / July 8, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a...
From
Novamind Inc.
Via
AccessWire
Novamind Launches Psychedelic Therapy Frontiers Podcast
June 30, 2021
Aimed at an audience of psychedelic medicine researchers and clinicians TORONTO, ON / ACCESSWIRE / June 30, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a...
From
Novamind Inc.
Via
AccessWire
Novamind Welcomes Dr. Paul Thielking as Chief Scientific Officer
June 23, 2021
- Led first-of-its-kind study of group psilocybin therapy for cancer patients with depression - Co-Investigator on a study to evaluate ketamine as a treatment for opioid use disorder - Will lead...
From
Novamind Inc.
Via
AccessWire
Topics
Death
Exposures
Death
Novamind Announces US$1,000,000 Strategic Investment in Stealth Mode Drug Development Company
June 17, 2021
TORONTO, ON / ACCESSWIRE / June 17, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, announces...
From
Novamind Inc.
Via
AccessWire
Novamind to Present at the H.C. Wainwright Psychedelics Conference on June 17, 2021
June 15, 2021
Novamind to be featured in panel discussions on the disruptive potential of psychedelic treatments TORONTO, ON / ACCESSWIRE / June 15, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind"...
From
Novamind Inc.
Via
AccessWire
Psyched: Atai's $214M IPO, MindMed CEO Resigns, Field Trip Applies To Nasdaq, Cybin And Novamind Target Frontline Health Workers
June 14, 2021
Atai Launches $214 Million Nasdaq IPO Offering Psychedelics biotech platform Atai life Sciences has announced an initi...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Novamind Launches Psychedelic Therapy Protocol for Frontline Healthcare Workers
June 10, 2021
Novamind and the Wholeness Center to launch clinical offering in Utah and Colorado TORONTO, ON / ACCESSWIRE / June 10, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind" or the...
From
Novamind Inc.
Via
AccessWire
Exposures
COVID-19
Novamind Reports Fiscal Q3 Financial Results and Operating Highlights
June 01, 2021
- Revenue of $1,846,132 for Fiscal Q3 2021, +43% quarter-over-quarter - Announced doubling of clinic network by September 2021 - Forecasting 65,000 clinic visits in 2021, +225% year-over-year TORONTO,...
From
Novamind Inc.
Via
AccessWire
Video: Experts Discuss Use Of Psychedelics In Mental Health Settings
May 11, 2021
The psychedelics industry has started to gain serious traction and is attracting lots of attention these days. However, what many people may not kn...
Via
Benzinga
Psyched: Groundbreaking Phase 3 Results On MDMA, Small Pharma, Wesana Go Public, Gilgamesh Raises $27M
May 10, 2021
Last week, the psychedelics space was moved by results from the world’s first Phase 3 clinical study of a scheduled psychedelic compound...
Via
Benzinga
Novamind And Field Trip Expand Footprint Of Psychedelic Clinics
May 05, 2021
Novamind Inc. (OTC:NVMDF), a company specializing in mental ...
Via
Benzinga
Novamind Announces Participation at the Planet MicroCap Showcase on April 20 - 22, 2021
April 20, 2021
TORONTO, ON / ACCESSWIRE / April 20, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, will...
From
Novamind Inc.
Via
AccessWire
Novamind to Present at the Planet MicroCap Virtual Event on April 22, 2021
April 19, 2021
TORONTO, ON / ACCESSWIRE / April 19, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, will...
From
Novamind Inc.
Via
AccessWire
Keynotes, Educational Panels and 66 Companies to Present at the Planet MicroCap Showcase: VIRTUAL on April 20-22, 2021
April 19, 2021
LOS ANGELES, CA / ACCESSWIRE / April 19, 2021 / The Planet MicroCap Showcase will take place on April 20-22, 2021, where 66 SmallCap, MicroCap and NanoCap public and private companies will be...
From
Stock News Now
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.